Codrix and Cholangiogram - a phase IV clinical study of FDA data
Summary:
We study 84 people who take Codrix (acetaminophen; codeine phosphate) or have Cholangiogram. No report of Cholangiogram is found in people who take Codrix.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Codrix?
Codrix has active ingredients of acetaminophen; codeine phosphate. It is often used in pain. eHealthMe is studying from 35 Codrix users. Check the latest studies of Codrix.
What is Cholangiogram?
Cholangiogram is found to be associated with 14 drugs and 29 conditions by eHealthMe. Check the latest studies of Cholangiogram.
No report is found.
Do you take Codrix and have Cholangiogram?
- Check whether Cholangiogram is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Codrix:
- Codrix (35 reports)
Cholangiogram treatments and more:
- Cholangiogram (49 reports)
How severe was Cholangiogram and when was it recovered:
Expand to all the drugs that have ingredients of acetaminophen; codeine phosphate:
Browse all side effects of Codrix:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Cholangiogram:
Browse all the conditions that are associated with Cholangiogram:
How the study uses the data?
The study uses data from the FDA. It is based on acetaminophen; codeine phosphate (the active ingredients of Codrix) and Codrix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Coumadin and Remodulin drug interactions for men aged 50-59 - now
- Fatigue and drugs of ingredients of ganciclovir - a second ago
- Could Bextra cause Fatigue? - 10 seconds ago
- Idiopathic Pulmonary Fibrosis and drugs of ingredients of treprostinil sodium - 17 seconds ago
- Could Fentanyl cause Flat Affect? - 18 seconds ago
- Fatigue and drugs of ingredients of gemfibrozil - 19 seconds ago
- Drug Ineffective and drugs of ingredients of clonazepam - 27 seconds ago
- Drug interactions of Lisinopril and Metopirone - 28 seconds ago
- Fatigue and drugs of ingredients of ranibizumab - 29 seconds ago
- Could Lidocaine cause Cushingoid? - 31 seconds ago